Decrease in Butyric Acid in fecal matter in patients with Inflammatory Bowel Disease is associated with the levels of secretory Immunoglobulin A and fecal calprotectin

被引：0
|
作者：
Izquierdo, L. V. Parra [1 ]
de Avila, J. [1 ]
Ramos, A. [1 ]
Chila-Moreno, L. [2 ]
Bello-Gualtero, J. M. [2 ]
Valdes, A. [3 ]
Morantes, S. [4 ]
Madronero, J. [5 ]
Bautista-Molano, W. [2 ]
Delgado, F. [5 ]
Florez-Sarmiento, C. [6 ]
Romero-Sanchez, C. [1 ,7 ]
机构：
[1] Univ El Bosque, Immunol, Cellular & Mol Immunol Grp INMUBO, Bogota, Colombia
[2] Univ Mil Nueva Granada, Immunol, Fac Med, Appl Clin Immunol Group, Bogota, Colombia
[3] Inst Invest Ciencias Alimentac CIAL CSIC UAM, Res, Madrid, Spain
[4] Univ El Bosque, Pharmaceut Chem, Pharmaceut Chem Programme Appl Chem Res Grp INQA, Bogota, Colombia
[5] Univ El Bosque, Virol, Vicerrectoria Inves, Inst Virol, Bogota, Colombia
[6] Hosp Int Colombia Bucaramanga Colombia, Gastroenterol, Bogota, Colombia
[7] Univ El Bosque, Immunol, Cellular & Mol Immunol Grp INMUBO, Bogota, Colombia
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P179
引用
收藏
页码：I482 / I482
页数：1
相关论文
共 50 条
  • [1] Fecal calprotectin in inflammatory bowel disease
    Walsham, Natalie E.
    Sherwood, Roy A.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2016, 9 : 21 - 29
  • [2] Fecal NGAL and Fecal Calprotectin in Inflammatory Bowel Disease Diagnosis
    Mukhametova, Dilyara
    Abdulganieva, Diana
    Valeeva, Ildariya
    Abdulhakov, Sayar
    Odintsova, Alfiya
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S45 - S45
  • [3] Utility of Fecal Calprotectin Levels for the Diagnosis of Inflammatory Bowel Disease in Patients with Spondyloarthritis
    Espinosa, Maria
    Ramos Giraldez, Consuelo
    Merino, Carolina
    Ruiz Antoran, Belen
    Campos, Jose
    Barbadillo, Carmen
    Godoy, Hilda
    Agudo, Belen
    Gonzalez, Yago
    Luis Andreu, Jose
    Sanz, Jesus
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] Pseudopolyps are associated with increased fecal calprotectin levels in patients with Inflammatory Bowel Disease in clinical and endoscopic remission
    Spigarelli De Rabago, I.
    Suarez Ferrer, C.
    Poza Cordon, J.
    Martin Arranz, E.
    Sanchez Azofra, M.
    Rueda Garcia, J. L.
    Suarez Cabredo, C. G.
    Hernandez Perez, M.
    Martin Arranz, M. D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S270 - S271
  • [5] Fecal Calprotectin for the Evaluation of Inflammatory Bowel Disease
    Bryce, Carl
    Bucaj, Merima
    AMERICAN FAMILY PHYSICIAN, 2021, 104 (02) : 303 - 304
  • [6] Fecal Calprotectin as a Predictor of Relapse in Patients With Inflammatory Bowel Disease
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (08) : 715 - 715
  • [7] Predictors of elevated fecal Calprotectin in Inflammatory Bowel Disease patients
    Shah, Rushikesh
    Herrera, Henry
    Dewald, Rosemarie
    Swaroop, Prabhakar
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S39 - S40
  • [8] A Functional Medicine Program for Patients With Inflammatory Bowel Disease and Improvement in Fecal Calprotectin Levels
    Strobel, Thomas M.
    Spring, Emily
    Horst, Sara
    Campbell, Sarah
    Robbins, Randi
    Dalal, Robin
    Scoville, Elizabeth
    Pabla, Baldeep
    Schwartz, David
    Beaulieu, Dawn Borromeo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2156 - S2157
  • [9] Fecal calprotectin levels and degree of inflammation in inflammatory bowel diseases patients
    Yordanova, M.
    Gerova, D.
    Atanasova, A.
    Galunska-Kalcheva, B.
    CLINICA CHIMICA ACTA, 2019, 493 : S359 - S360
  • [10] Fecal Calprotectin as a Screening Marker for Inflammatory Bowel Disease
    Sridhar, Mathrubootham
    Kesavelu, Dhanasekhar
    INDIAN PEDIATRICS, 2019, 56 (03) : 249 - 250
12345